
    
      Fecal microbiota transplantation (FMT) is a technique in which intestinal microbiota are
      transferred from a healthy donor to the patient, with as primary goal to introduce - or
      restore - a stable and 'healthy' microbial community in the gut.

      Parkinson's disease (PD) is a neurodegenerative disorder characterized by motor symptoms and
      Gastrointestinal dysfunction, in particular constipation, affects up to 80% of PD patients
      and may precede the onset of motor symptoms by years.

      this study include one group of PD patients that will receive FMT. two other groups will
      serve as controls:

        1. PD patients that will not receive FMT

        2. healthy people who live with PD patients in the same house and share similar surrounding
    
  